Oryzon to initiate phase II ESCAPE study of vafidemstat in severely ill COVID-19 patients in Spain April 27, 2020
SARS-CoV-2 requires ACE2 and TMPRSS2 for cell entry, which may be blocked by a TMPRSS2 inhibitor April 27, 2020
GARNET data show potential of dostarlimab in recurrent or advanced dMMR endometrial cancer April 24, 2020
Phase III PROfound trial of Lynparza in CRPC shows statistically significant improvement in OS April 24, 2020
RSS